PLX
Protalix Biotherapeutics Inc
2.70$
-2.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -55.8% | -100.0% | – | – | – | – | -65.1% | +0.0% | – | – | – | +2,797.9% | -25.4% | +310.5% | -66.6% | +31.7% | -71.2% | +110.8% | +129.1% | +62.4% | +59.7% | +15.0% | -39.0% | +24.2% | +37.5% | -18.5% | -1.2% | |
| – | – | – | -57.4% | – | – | – | – | – | – | +0.0% | +6,340.0% | – | – | +22.6% | -65.2% | +434.0% | -33.3% | +66.8% | -91.9% | +1,050.4% | +81.4% | -38.9% | +17.1% | -0.2% | +50.4% | +19.8% | +17.3% | +5.8% | +13.1% | |
| – | – | – | -49.6% | -100.0% | – | – | – | – | -62.9% | +0.0% | – | – | – | – | -79.0% | +1,721.2% | -76.8% | +0.4% | -40.5% | -78.0% | +630.0% | +326.5% | +75.6% | +18.8% | -57.7% | +27.5% | +51.6% | -31.6% | -13.2% | |
| – | – | – | – | – | – | – | – | – | – | +48.9% | +145.2% | +35.3% | +24.3% | +38.4% | +3.6% | -7.6% | +1.9% | -6.4% | -26.8% | +51.9% | -5.2% | +15.6% | +33.9% | -14.5% | -22.1% | -1.3% | -41.8% | -24.1% | +46.9% | |
| – | +273.1% | +1,169.2% | -26.9% | -74.9% | -23.6% | -43.2% | -11.1% | +12.3% | -43.7% | +4,750.2% | +158.7% | -42.2% | +5.5% | -3.8% | +0.8% | +40.9% | -14.1% | +15.2% | -24.7% | +28.5% | +23.2% | -83.2% | +207.9% | -14.7% | -21.0% | +237.8% | +87.5% | +60.2% | -71.4% | |
| – | +273.1% | +1,666.6% | -41.9% | -77.4% | +1.0% | -57.0% | -11.1% | +12.3% | -43.7% | +10,373.2% | +127.7% | +8.7% | +19.1% | +28.0% | +3.1% | +1.3% | -11.4% | -8.1% | -12.8% | +24.4% | +18.8% | +9.6% | +23.2% | -9.5% | -13.9% | -3.3% | -21.9% | -21.5% | +22.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -855.1% | – | – | -62.6% | -240.4% | |
| – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | +83.0% | -99.8% | +1,600.0% | +1,882.4% | +632.2% | -24.3% | +12.2% | +132.0% | -21.0% | +3.7% | +21.4% | -22.2% | -66.4% | +25.7% | -66.6% | +12.1% | |
| – | -10.1% | – | – | – | – | – | – | – | – | – | – | – | +40.3% | -7.8% | -100.0% | -581,000.0% | – | – | – | – | – | – | – | – | – | – | – | -51.5% | -235.0% | |
| – | -10.3% | -144.7% | – | -169.4% | – | – | – | +13.8% | -108.8% | – | -118.7% | – | +40.3% | -22.4% | -11.2% | -100.0% | – | – | – | – | -28.1% | -93.1% | +1,386.2% | +5.1% | -23.5% | -91.7% | -52.1% | +381.1% | -18.5% | |
| – | -10.1% | -1,068.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -150.6% | – | – | – | – | – | – | – | -64.7% | -325.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -525.7% | – | – | -49.6% | -145.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.